Cell and animal models of SARS-CoV-2 pathogenesis and immunity
The spread of the novel virus SARS coronavirus 2 (SARS-CoV-2) was explosive, with cases first identified in December 2019, and >22 million people infected and >775,000 deaths as of August 2020. SARS-CoV-2 can cause severe respiratory disease in humans leading to coronavirus disease 2019 (COVID...
Main Authors: | Sarah R. Leist, Alexandra Schäfer, David R. Martinez |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2020-09-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/13/9/dmm046581 |
Similar Items
-
Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01) -
An overview of SARS-COV-2: Virology, Epidemiology, Pathogenesis and Treatment
by: Ramesh Bhandari, et al.
Published: (2020-06-01) -
In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01) -
SARS, SARS again, and MERS. Review of animal models of human respiratory syndromes caused by coronavirus infections
by: Aleksey M. Nagornykh, et al.
Published: (2020-11-01) -
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)